BD 256095 - SARS-CoV-2 and Flu A+B Kit Analyzer Combo with Veritor Plus Analyzer and Dual Respiratory Test Kits

BD 256095 - SARS-CoV-2 and Flu A+B Kit Analyzer Combo with Veritor Plus Analyzer and Dual Respiratory Test Kits

The BD 256095 Veritor SARS/Flu Kit + Analyzer Combo is a comprehensive point-of-care diagnostic testing solution designed to detect SARS-CoV-2 and Influenza A+B using a single integrated testing platform. The package includes one BD Veritor Plus Analyzer and two BD Veritor SARS-CoV-2 & Flu A+B test kits, providing healthcare facilities with a convenient solution for respiratory illness evaluation and differential testing.

The BD Veritor Plus Analyzer delivers automated digital interpretation of test results, helping reduce subjective visual reading and supporting standardized result reporting. By combining COVID-19 and influenza testing capabilities into a single assay platform, the system helps clinicians evaluate patients presenting with overlapping respiratory symptoms more efficiently.

This solution is intended for professional healthcare settings that require rapid respiratory pathogen testing to support patient management, infection control efforts, and clinical decision-making.

Key Benefits

The BD 256095 Combo enables healthcare providers to evaluate patients for both SARS-CoV-2 and Influenza A+B using a single test platform, helping streamline respiratory diagnostic workflows and reduce testing complexity.

The automated analyzer interpretation helps improve result consistency by minimizing variability associated with visual test reading. This can support more standardized testing practices across multiple users and clinical locations.

Rapid testing capabilities support timely patient triage, treatment planning, isolation decisions, and infection prevention measures, particularly during periods when influenza and COVID-19 are both circulating within the community.

The bundled analyzer and test kit configuration simplifies implementation and provides a ready-to-use diagnostic solution for eligible healthcare facilities.

Compatibility and Applications

The BD 256095 Combo is designed for use with the included BD Veritor Plus Analyzer and compatible BD Veritor SARS-CoV-2 & Flu A+B test kits. The analyzer platform supports automated processing and interpretation of approved BD Veritor assays.

Typical applications include respiratory illness evaluation, COVID-19 screening, influenza testing, urgent care diagnostics, outpatient respiratory assessment, occupational health testing, infection prevention programs, and seasonal respiratory disease management.

This product is commonly used in physician offices, urgent care centers, outpatient clinics, community health centers, occupational health facilities, retail health clinics, and other professional healthcare environments.

Usage Guidelines

Use the BD 256095 Veritor SARS/Flu Kit + Analyzer Combo only by trained healthcare personnel following manufacturer instructions, facility protocols, applicable CLIA requirements, and current public health guidance.

Before testing, verify analyzer functionality, test kit expiration dates, storage conditions, and quality control requirements. Collect and process specimens according to the instructions supplied with the BD Veritor SARS-CoV-2 & Flu A+B test kits.

After specimen preparation, insert the completed test device into the BD Veritor Plus Analyzer for automated result interpretation. Record and report results according to institutional policies and regulatory requirements.

Certifications and Safety Standards

The BD Veritor testing platform is manufactured under established quality management systems and is designed to support professional diagnostic testing applications. The analyzer and associated test kits should be used according to current product labeling, quality control procedures, and applicable regulatory authorizations.

Healthcare facilities should review current product documentation, regulatory status, testing instructions, and quality assurance requirements before implementation. Compliance with federal, state, local, and laboratory regulations should be maintained at all times.

Comparison with Competitor Products

Compared with separate COVID-19 and influenza testing workflows, the BD Veritor SARS-CoV-2 & Flu A+B assay allows simultaneous evaluation for multiple respiratory pathogens using a single testing platform, helping improve operational efficiency.

Compared with visually interpreted rapid tests, the Veritor Plus Analyzer provides objective digital result interpretation, helping reduce variability and support consistent reporting across different operators.

Compared with laboratory-based molecular testing methods that may require longer turnaround times, this point-of-care platform supports rapid diagnostic assessment, helping healthcare providers make timely clinical decisions.

Typical User Profile and Application Scenarios

The BD 256095 Combo is commonly used by physicians, nurse practitioners, physician assistants, nurses, medical assistants, laboratory personnel, infection prevention specialists, and occupational health professionals involved in respiratory illness testing.

Typical applications include evaluation of patients with respiratory symptoms, seasonal respiratory illness screening, urgent care diagnostics, outpatient infectious disease assessment, workplace health programs, and community healthcare testing initiatives.

Best Practices for Use and Maintenance

Store the analyzer and test kits according to manufacturer specifications and maintain proper environmental conditions throughout storage and use. Monitor inventory to ensure testing materials remain within approved expiration periods.

Perform routine analyzer maintenance, quality control testing, and performance verification according to manufacturer recommendations. Ensure all operators receive appropriate training and competency validation before performing patient testing.

Maintain complete documentation of testing activities, quality control procedures, maintenance records, and patient results in accordance with facility policies and applicable regulatory requirements.

Regulatory and Safety Information

The BD 256095 Veritor SARS/Flu Kit + Analyzer Combo is intended for professional healthcare use only. Testing should be performed by trained personnel following manufacturer instructions, infection control procedures, applicable CLIA requirements, and healthcare regulations.

All patient specimens should be treated as potentially infectious. Appropriate personal protective equipment should be used during specimen collection, handling, and testing. Facilities should maintain compliance with applicable federal, state, and local requirements governing diagnostic testing.

This product is designated as non-cancellable and non-returnable. Facilities should verify testing requirements, compatibility, and purchasing needs prior to ordering.

How to Order

Select the BD 256095 Veritor SARS-CoV-2 and Flu A+B Kit Analyzer Combo Including Two SARS/Flu Test Kits and One Veritor Plus Analyzer and add it to your cart. Complete checkout with your preferred shipping and payment options. This product is available for Continental US shipment only and is non-cancellable and non-returnable. For bulk orders, quotes, implementation assistance, or further product information, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.